Literature DB >> 9666034

Rapid screening tests for determining in vitro susceptibility of herpes simplex virus clinical isolates.

P de la Iglesia1, S Melón, B López, M Rodriguez, M I Blanco, P Mellado, M de Oña.   

Abstract

The susceptibility of human herpes simplex virus (HSV) to acyclovir (ACV) was determined with the use of a single dose of the drug (1 and 2 micrograms of ACV per ml for HSV-1 and HSV-2, respectively) in two rapid assays: a rapid cytopathic effect inhibitory assay (Rapid CIA) and a rapid dye uptake assay (Rapid DUA). These tests allow the simultaneous determination of virus titer and susceptibility to ACV at a determined viral concentration (100 50% tissue culture infective doses and 100 50% dye uptake units). These tests were compared with a conventional susceptibility assay (dye uptake assay) and showed similar results. Indeterminate results with the Rapid CIA appeared in 3 of 30 samples. With the use of both Rapid CIA and Rapid DUA, we were able to determine the susceptibility of 100% of the isolates. The rapid tests, unlike conventional assays, are able to provide susceptibility results within 3 days after the virus has been isolated from a clinical specimen and could thus play a direct role in therapeutic decisions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9666034      PMCID: PMC105060     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

Review 1.  Acyclovir: a decade later.

Authors:  R J Whitley; J W Gnann
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

Review 2.  Resistance of herpesviruses to antiviral drugs.

Authors:  P A Chatis; C S Crumpacker
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

3.  Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus.

Authors:  E M Swierkosz; D R Scholl; J L Brown; J D Jollick; C A Gleaves
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

4.  Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient.

Authors:  R G Kost; E L Hill; M Tigges; S E Straus
Journal:  N Engl J Med       Date:  1993-12-09       Impact factor: 91.245

5.  A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents.

Authors:  C McLaren; M N Ellis; G A Hunter
Journal:  Antiviral Res       Date:  1983-11       Impact factor: 5.970

Review 6.  Virus resistance in clinical practice.

Authors:  C Dekker; M N Ellis; C McLaren; G Hunter; J Rogers; D W Barry
Journal:  J Antimicrob Chemother       Date:  1983-09       Impact factor: 5.790

7.  Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.

Authors:  J A Englund; M E Zimmerman; E M Swierkosz; J L Goodman; D R Scholl; H H Balfour
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

  7 in total
  4 in total

1.  Use of a single monoclonal antibody to determine the susceptibilities of herpes simplex virus type 1 and type 2 clinical isolates to acyclovir.

Authors:  Christine Chutkowski; Betty Olson; Ann McDonough; James Mahoney; James J McSharry
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  A rapid phenotypic assay for detection of acyclovir-resistant varicella-zoster virus with mutations in the thymidine kinase open reading frame.

Authors:  R Sahli; G Andrei; C Estrade; R Snoeck; P R Meylan
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

3.  Sulfonated and Carboxymethylated β-Glucan Derivatives with Inhibitory Activity against Herpes and Dengue Viruses.

Authors:  José Louzinho Lopes; Vinicius Seiki Takemura Quinteiro; Jéssica Wouk; Maria Laura Darido; Robert F H Dekker; Aneli M Barbosa-Dekker; Václav Vetvicka; Mário A A Cunha; Ligia Carla Faccin-Galhardi; Alexandre Orsato
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

4.  Herpes simplex virus: isolation, cytopathological characterization and antiviral sensitivity.

Authors:  Carlos Nozawa; Lilian Yumi Hattori; Ligia Carla Faccin Galhardi; Nayara Lopes; Wesley Andrade Bomfim; Ligyana Korki de Cândido; Elbens Marcos Minoreli de Azevedo; Airton dos Santos Gon; Rosa Elisa Carvalho Linhares
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.